Abstract
Objective: Osteoporosis (OP) is highly prevalent among patients with inflammatory rheumatic and musculoskeletal diseases (iRMDs), yet it remains frequently underdiagnosed and undertreated in this population. This study aimed to evaluate the levels of osteoporosis knowledge and awareness among patients diagnosed with iRMDs.Methods: A total of 120 patients with iRMDs (56 males, 64 females; mean age: 41 ± 11.9 years) were included in this cross-sectional study. Demographic data, disease diagnosis, and disease duration were recorded. Participants were surveyed regarding general aspects of osteoporosis, nutrition, and exercise. OP knowledge was assessed using the Revised Osteoporosis Knowledge Test (OKT), and awareness was evaluated via the Osteoporosis Awareness Scale (OAS).Results: Of the patients included in the study, 79 (65.8%) knew they were at high risk for osteoporosis. Both OP awareness (73.6 ± 18.7) and knowledge scores (15.4 ± 4.97) were found to be suboptimal among iRMD patients. A strong positive correlation was identified between educational attainment and both OKT and OAS scores. Participants receiving corticosteroid therapy exhibited significantly higher levels of OP awareness. Furthermore, a positive association was observed between physical activity levels and OAS scores.Conclusion: The results of this study indicated that although the vast majority of patients with iRMDs perceive themselves to be in a high-risk group for OP, their level of knowledge regarding OP is low and their awareness level is insufficient. To reduce the incidence of osteoporosis and its associated morbidity and mortality, patient education programs should be organized specifically for patients with iRMDs.
Keywords: Awareness; knowledge; osteoporosis; inflammatory rheumatic diseases.
References
- Sozen T, Ozisik L, Calik Basaran N. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4(1):46-56. Crossref
- Buttgereit F, Palmowski A, Bond M, et al. Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases. Nat Rev Rheumatol. 2024;20(7):417-431. Crossref
- Schett G, Kiechl S, Weger S, et al. High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med. 2006;166(22):2495-2501. Crossref
- Mun H, Liu B, Pham THA, et al. C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches. Osteoporos Int. 2021;32(3):425-435. Crossref
- Raterman HG, Lems WF. Pharmacological management of osteoporosis in rheumatoid arthritis patients: a review of the literature and practical guide. Drugs Aging. 2019;36(12):1061-1072. Crossref
- Briot K, Geusens P, Bultink IEM, et al. Inflammatory diseases and bone fragility. Osteoporos Int. 2017;28(12):3301-3314. Crossref
- Wiebe E, Huscher D, Schaumburg D, et al. Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease. Ann Rheum Dis. 2022;81(10):1313-1322. Crossref
- Gendler PE, Coviak CP, Martin JT, et al. Revision of the osteoporosis knowledge test: reliability and validity. West J Nurs Res. 2015;37(12):1623-1643. Crossref
- Atalay NŞ, Akkaya N, Şahin F. Revize 2011-Osteoporoz Bilgi Testi'nin Türkçe versiyonunun psikometrik özellikleri. Turk Osteoporoz Derg. 2015;21(3):127-131. Crossref
- Aktürk SO, Meseri R, Özentürk MG. The psychometric property evaluation of the Turkish version of the osteoporosis awareness scale. Turk J Osteoporos. 2021;27(2):151-158. Crossref
- Karamanlioglu DS. Awareness of osteoporosis, osteoporosis knowledge levels, and associated factors in individuals with Rheumatoid Arthritis. Dicle Med J. 2025;52(1):17-29. Crossref
- Aksoy ÖT, Kutluk Ö, Sezer İ. Osteoporosis knowledge and awareness among rheumatoid arthritis patients: A cross-sectional controlled study. Arch Rheumatol. 2024;39(3):411-418. Crossref
- Gemalmaz A, Oge A. Knowledge and awareness about osteoporosis and its related factors among rural Turkish women. Clin Rheumatol. 2008;27(6):723-728. Crossref
- Kurt EE, Koçak FA, Tuncay F, et al. Knowledge Level and Awareness about Osteoporosis among Risk Group of Rural Women. Turk J Osteoporos. 2015;21(2):63-68. Crossref
- Şahin E, Dilek B, Baydar M, et al. Awareness of osteoporosis and its related factors after distal radius fractures in patients aged 45 years and older. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi. 2013;59(1):52-56.
- Büyükvural Şen S, Kaya E, Aygün Bilecik N. Spinal kord yaralanmalı hastalarda osteoporoz bilgi ve farkındalık düzeyi. Turk J Osteoporos. 2022;28(3):188-192. Crossref
- Karakaş A, Gündüz NE, Özçelik S, et al. Awareness and knowledge levels of osteoporosis in patients with multiple sclerosis. Turk J Osteoporos. 2022;28(2):131-136. Crossref
- Buttgereit F. Views on glucocorticoid therapy in rheumatology: the age of convergence. Nat Rev Rheumatol. 2020;16(4):239-246. Crossref
- Kavak SK, Aktekin L, Kavak EE, et al. Osteoporosis Awareness and Knowledge in Postmenopausal Breast Cancer Survivors. Turk J Osteoporos. 2024;30(1):30-36. Crossref
- Dontas IA, Yiannakopoulos CK. Risk factors and prevention of osteoporosis-related fractures. J Musculoskelet Neuronal Interact. 2007;7(3):268-272.
- Foley S, Quinn S, Jones G. Pedometer determined ambulatory activity and bone mass: A population-based longitudinal study in older adults. Osteoporos Int. 2010;21(11):1809-1816. Crossref
- Akyol Y, Ulus Y, Bilgici A, et al. Premenopozal ve Postmenopozal Kadınlarda Osteoporoz Bilgi ve Farkındalık Düzeyinin Karşılaştırılması. Turk J Osteoporos. 2020;26(1):10-18. Crossref
Cite this article
Sıdıka Büyükvural Şen, Alper Yıldırım. Knowledge and Awareness Levels of Osteoporosis in Patients with Inflammatory Rheumatic Diseases. Journal of Cukurova Anesthesia and Surgical Sciences. 9(1):34-39. https://doi.org/10.36516/jocass.1855253